SenGenix
Durham, US · Founded 2012 · Delaware corporation
Founders & leadership
SC
Sandra CummingsExecutive
RS
Richard S. SurwitExecutive
Board
HH
Homme HellingaBoard director
RS
Ralph SnydermanBoard director
LC
Lawrence CohenBoard director
Reported raises · per SEC filings
Form D private placements$10.8M disclosed across 4 rounds · 2013–2017
▶$6.3MraisedOct 2017 · 18 investors · BiotechnologyRule 506(b)
▶$6.3MraisedOct 2017 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard S. SurwitExecutive Officer, Director
- Homme HellingaExecutive Officer, Director
- Lawrence CohenDirector
- Ralph SnydermanDirector
- Sandra E. CummingsExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $6.3M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedSep 2016 · 11 investors · BiotechnologyRule 506(b)
▶$1.5MraisedSep 2016 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lawrence CohenDirector
- Ralph SnydermanDirector
- Richard S. SurwitExecutive Officer, Director
- Sandra E. CummingsExecutive Officer, Director
- Homme HellingaExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1.1MraisedOct 2015 · 7 investors · BiotechnologyRule 506(b)
▶$1.1MraisedOct 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Homme HellingaDirector
- Ralph SnydermanDirector
- Lawrence CohenDirector
- Sandra CummingsExecutive Officer, Director
- Richard S. SurwitExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$2MraisedJul 2014 · 15 investors · BiotechnologyRule 506(b)
▶$2MraisedJul 2014 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard S. SurwitExecutive Officer, Director
- Homme HellingaDirector
- Ralph SnydermanDirector
- Lawrence CohenDirector
- Sandra CummingsExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2M
- First sale
- Aug 2013
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has SenGenix raised?
- SenGenix has disclosed $10.8M raised across 4 rounds.
- Where is SenGenix headquartered?
- SenGenix is headquartered in Durham, US.